User profiles for Roxana Daneshjou

Roxana Daneshjou, MD, PhD

Assistant Professor of Biomedical Data Science and Dermatology, Stanford University
Verified email at stanford.edu
Cited by 3141

Disparities in dermatology AI performance on a diverse, curated clinical image set

R Daneshjou, K Vodrahalli, RA Novoa, M Jenkins… - Science …, 2022 - science.org
An estimated 3 billion people lack access to dermatological care globally. Artificial intelligence
(AI) may aid in triaging skin diseases and identifying malignancies. However, most AI …

How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals

E Wu, K Wu, R Daneshjou, D Ouyang, DE Ho, J Zou - Nature Medicine, 2021 - nature.com
A comprehensive overview of medical AI devices approved by the US Food and Drug
Administration sheds new light on limitations of the evaluation process that can mask …

Lack of transparency and potential bias in artificial intelligence data sets and algorithms: a scoping review

R Daneshjou, MP Smith, MD Sun… - JAMA …, 2021 - jamanetwork.com
Importance Clinical artificial intelligence (AI) algorithms have the potential to improve
clinical care, but fair, generalizable algorithms depend on the clinical data on which they are …

[HTML][HTML] Large language models propagate race-based medicine

…, S Spichak, V Rotemberg, R Daneshjou - NPJ Digital …, 2023 - nature.com
Large language models (LLMs) are being integrated into healthcare systems; but these
models may recapitulate harmful, race-based medicine. The objective of this study is to assess …

Bioinformatics challenges for personalized medicine

GH Fernald, E Capriotti, R Daneshjou… - …, 2011 - academic.oup.com
Motivation: Widespread availability of low-cost, full genome sequencing will introduce new
challenges for bioinformatics. Results: This review outlines recent developments in …

Data-driven prediction of drug effects and interactions

NP Tatonetti, PP Ye, R Daneshjou… - Science translational …, 2012 - science.org
Adverse drug events remain a leading cause of morbidity and mortality around the world.
Many adverse events are not detected during clinical trials before a drug receives approval for …

[HTML][HTML] Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study

…, ER Gamazon, A Konkashbaev, R Daneshjou… - The Lancet, 2013 - thelancet.com
Background VKORC1 and CYP2C9 are important contributors to warfarin dose variability,
but explain less variability for individuals of African descent than for those of European or …

Checklist for evaluation of image-based artificial intelligence reports in dermatology: CLEAR derm consensus guidelines from the international skin imaging …

R Daneshjou, C Barata, B Betz-Stablein… - JAMA …, 2022 - jamanetwork.com
Importance The use of artificial intelligence (AI) is accelerating in all aspects of medicine
and has the potential to transform clinical care and dermatology workflows. However, to …

Black box warning: large language models and the future of infectious diseases consultation

IS Schwartz, KE Link, R Daneshjou… - Clinical Infectious …, 2024 - academic.oup.com
Large language models (LLMs) are artificial intelligence systems trained by deep learning
algorithms to process natural language and generate text responses to user prompts. Some …

Towards transparency in dermatology image datasets with skin tone annotations by experts, crowds, and an algorithm

M Groh, C Harris, R Daneshjou, O Badri… - Proceedings of the ACM …, 2022 - dl.acm.org
While artificial intelligence (AI) holds promise for supporting healthcare providers and
improving the accuracy of medical diagnoses, a lack of transparency in the composition of …